» Articles » PMID: 29980190

Diabetes Mellitus in HIV-infected Patients: Fasting Glucose, A1c, or Oral Glucose Tolerance Test - Which Method to Choose for the Diagnosis?

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2018 Jul 8
PMID 29980190
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Antiretroviral therapy dramatically reduced HIV-related morbidity and mortality, prolonging the lifespan of HIV-infected patients. Greater duration of infection and exposure to antiretroviral therapy makes these patients susceptible to traditional cardio-metabolic risk factors and pathologies. The optimal diagnostic protocol for Diabetes Mellitus in these patients is still controversial. Haemoglobin A1c (HbA1c) has been shown to underestimate glycaemia levels and the oral glucose tolerance test (OGTT) has been shown to reveal cases of glucose metabolism disturbances in patients with normal fasting glucose. Thus, this study aimed to determine the prevalence of prediabetes and diabetes in a population of HIV-infected patients undergoing combined antiretroviral therapy, using three different diagnostic methods (fasting glucose, OGTT and HbA1c), to determine the agreement between the different methods and the characteristics associated with each one.

Methods: This study analyzed 220 HIV-infected patients on antiretroviral therapy. Patient characteristics were collected using a standardized protocol. Disturbances of glucose homeostasis were defined by the ADA 2017 criteria. Patients were characterized according to the presence or absence of clinical lipodystrophy, and distributed into four different categories, according to the presence, or absence of either clinical lipoatrophy, or abdominal prominence. Insulin resistance was assessed by HOMA-IR and QUICKI indexes. Agreement between the diagnostic methods was assessed by Cohen's kappa coefficient.

Results: There were no patients diagnosed with diabetes with HbA1c. 5.9% prevalence was obtained when OGTT was used, and 3.2% prevalence when fasting glucose was used. Prediabetes had a prevalence of 14.1% when using HbA1c, 24.1% when using OGTT, and 20% when using fasting glucose. In all three methods, glucose homeostasis disturbances were associated with older age and higher resistance to insulin. Regarding other characteristics, associations varied between the three methods. The agreement between them was fair, or slight.

Conclusions: We observed that HbA1c was the method that diagnosed the least amount of cases and that OGTT was the one that diagnosed the most cases. Accordingly, our results indicate that HbA1c underestimated glycaemia levels in this population and that the use of OGTT might allow an earlier diagnosis of glucose homeostasis disturbances, potentially making it possible to avoid severe complications of DM.

Citing Articles

Elevated liver enzymes and diabetes in the PERSIAN Guilan cohort study.

Ashoobi M, Joukar F, Mojtahedi K, Maroufizadeh S, Javid M, Parvaneh A Caspian J Intern Med. 2024; 16(1):73-82.

PMID: 39619755 PMC: 11607110. DOI: 10.22088/cjim.16.1.73.


An update on drug-drug interactions in older adults living with human immunodeficiency virus (HIV).

Linfield R, Nguyen N, Laprade O, Holodniy M, Chary A Expert Rev Clin Pharmacol. 2024; 17(7):589-614.

PMID: 38753455 PMC: 11233252. DOI: 10.1080/17512433.2024.2350968.


Diabetes and Multiple Long-term Conditions: A Review of Our Current Global Health Challenge.

Khunti K, Chudasama Y, Gregg E, Kamkuemah M, Misra S, Suls J Diabetes Care. 2023; 46(12):2092-2101.

PMID: 38011523 PMC: 10698221. DOI: 10.2337/dci23-0035.


The prevalence of hyperglycemia and its impact on mortality among people living with HIV in Georgia.

Borkowska T, Chkhartishvili N, Karkashadze E, Chokoshvili O, Gabunia P, Sharvadze L PLoS One. 2022; 17(10):e0276749.

PMID: 36301817 PMC: 9612544. DOI: 10.1371/journal.pone.0276749.


The risk of hyperglycemia associated with use of dolutegravir among adults living with HIV in Kampala, Uganda: A case-control study.

Namara D, Schwartz J, Tusubira A, McFarland W, Birungi C, Semitala F Int J STD AIDS. 2022; 33(14):1158-1164.

PMID: 36222490 PMC: 9691558. DOI: 10.1177/09564624221129410.


References
1.
Duran L, Rodriguez C, Drozd D, Nance R, Delaney J, Burkholder G . Fructosamine and Hemoglobin A1c Correlations in HIV-Infected Adults in Routine Clinical Care: Impact of Anemia and Albumin Levels. AIDS Res Treat. 2015; 2015:478750. PMC: 4529884. DOI: 10.1155/2015/478750. View

2.
De Wit S, Sabin C, Weber R, Worm S, Reiss P, Cazanave C . Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care. 2008; 31(6):1224-9. PMC: 2746200. DOI: 10.2337/dc07-2013. View

3.
Seang S, Lake J, Tian F, Anastos K, Cohen M, Tien P . Oral Glucose Tolerance Testing identifies HIV+ infected women with Diabetes Mellitus (DM) not captured by standard DM definition. J AIDS Clin Res. 2016; 7(2). PMC: 4825684. DOI: 10.4172/2155-6113.1000545. View

4.
. 3. Comprehensive Medical Evaluation and Assessment of Comorbidities. Diabetes Care. 2016; 40(Suppl 1):S25-S32. DOI: 10.2337/dc17-S006. View

5.
Brar I, Shuter J, Thomas A, Daniels E, Absalon J . A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort. J Acquir Immune Defic Syndr. 2007; 45(1):66-71. DOI: 10.1097/QAI.0b013e318031d7e3. View